|
HEATR5B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.97369999735508E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.38390032345637E-10 |
| Normal-vs-Stage2 |
2.424600E-03 |
| Normal-vs-Stage3 |
5.804400E-04 |
| Normal-vs-Stage4 |
6.436400E-02 |
| Stage1-vs-Stage2 |
5.951800E-01 |
| Stage1-vs-Stage3 |
5.244400E-02 |
| Stage1-vs-Stage4 |
2.144700E-03 |
| Stage2-vs-Stage3 |
4.224200E-01 |
| Stage2-vs-Stage4 |
9.568100E-02 |
| Stage3-vs-Stage4 |
1.947830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.12459999979109E-07 |
| Normal-vs-AfricanAmerican |
7.410900E-04 |
| Normal-vs-Asian |
1.243480E-04 |
| Caucasian-vs-AfricanAmerican |
7.772000E-01 |
| Caucasian-vs-Asian |
1.843360E-01 |
| AfricanAmerican-vs-Asian |
2.205400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.04929999997528E-06 |
| Normal-vs-Female |
3.33960004095246E-09 |
| Male-vs-Female |
3.214300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.788800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.29480000452287E-08 |
| Normal-vs-Age(61-80Yrs) |
4.50479999969389E-07 |
| Normal-vs-Age(81-100Yrs) |
4.463600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.350440E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.049000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.221600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.764600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.933900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.326840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.20760118255726E-11 |
| Normal-vs-Grade 2 |
6.81460443630044E-11 |
| Normal-vs-Grade 3 |
2.48609999999871E-05 |
| Normal-vs-Grade 4 |
7.566800E-01 |
| Grade 1-vs-Grade 2 |
1.741660E-03 |
| Grade 1-vs-Grade 3 |
5.221200E-04 |
| Grade 1-vs-Grade 4 |
1.70440000002436E-07 |
| Grade 2-vs-Grade 3 |
6.004400E-03 |
| Grade 2-vs-Grade 4 |
6.95149999785372E-08 |
| Grade 3-vs-Grade 4 |
1.838420E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
3.267800E-01 |
| ccA subtype-vs-ccB subtype |
4.44089209850063E-16 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.2046999999793E-06 |
| Normal-vs-N1 |
3.452000E-01 |
| N0-vs-N1 |
2.519000E-01 |
|
|
